Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eledon Pharmaceuticals (ELDN) Other Operating Expenses (2016 - 2025)

Eledon Pharmaceuticals filings provide 2 years of Other Operating Expenses readings, the most recent being -$2.1 million for Q4 2017.

  • On a quarterly basis, Other Operating Expenses rose 53.9% to -$2.1 million in Q4 2017 year-over-year; TTM through Dec 2017 was -$11.8 million, a 60.55% increase, with the full-year FY2025 number at $7.5 million, up 111.67% from a year prior.
  • Other Operating Expenses hit -$2.1 million in Q4 2017 for Eledon Pharmaceuticals, up from -$2.8 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of -$2.1 million in Q4 2017 to a low of -$14.5 million in Q2 2016.